CG Oncology, Inc.
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
CGON$74.74-1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber · Exhibit Description · Incorporated by Reference · FiledHerewith | |||||
|---|---|---|---|---|---|
| Form · Date · Number | |||||
| 3.1 | Amended and Restated Certificate of Incorporation | S-1/A | 01/18/24 | 3.3 | |
| 3.2 | Amended and Restated Bylaws | S-1 | 01/02/24 | 3.4 | |
| 4.1 | Specimen stock certificate evidencing the shares of common stock | S-1/A | 01/18/24 | 4.1 | |
| 4.2 | Amended and Restated Investors’ Rights Agreement, dated July 28, 2023, as amended, by and among the Registrant and certain of its stockholders | S-1/A | 01/18/24 | 4.2 | |
| 10.1** | Convertible Promissory Note between the Registrant's subsidiary, SafeGuard Healthcare, LLC, and SP Healthcare SPV I, LLC dated February 3, 2025 | X | |||
| 10.2# | Amended and Restated Non-Employee Director Compensation Program | 10-K | 03/28/25 | 10.5 | |
| 10.3# | Amended and Restated Employment Agreement, effective January 9, 2025, between Arthur Kuan and the Registrant | 10-K | 03/28/25 | 10.11 | |
| 10.4# | Amended and Restated Employment Agreement, effective January 9, 2025, between Ambaw Bellete and the Registrant | 10-K | 03/28/25 | 10.12 | |
| 10.5# | Amended and Restated Employment Agreement, effective January 9, 2025, between Vijay Kasturi and the Registrant | 10-K | 03/28/25 | 10.13 | |
| 10.6# | Amended and Restated Employment Agreement, effective January 9, 2025, between Corleen Roche and the Registrant | 10-K | 03/28/25 | 10.14 | |
| 10.7# | Amended and Restated Employment Agreement, effective January 9, 2025, between Joshua F. Patterson and the Registrant | 10-K | 03/28/25 | 10.15 | |
| 31.1 | Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | |||
| 31.2 | Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | |||
| 32.1* | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||
| 32.2* | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||
| 101.INS | Inline XBRL Instance Document | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Document | X | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
- This certification is not being filed for purposes of Section 18 of the Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
** Portions of the exhibit (indicated by “[***]”) have been omitted because they are not material and would likely cause competitive harm to us if disclosed.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.